Therefore, compared with normal adjacent tissues, the high level of AKR1C1 in bladder cancer tissues was more capable of eliminating the anticancer activity of multiple drugs and gained certain advantages for the chemotherapy resistance of bladder cancer. This evidence concerns the gene AKR1C1 and urinary bladder cancer.